Principal Investigator
Maria Carpintero
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240472
Clinical Trial Summary
HZNP-DAZ-303-A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjgren’s Syndrome With Moderate-to-Severe Symptom State
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu